About Dr Gareth Baynam
Professor Baynam is an internationally recognised expert in transformational rare diseases research, clinical implementation (including leading state-wide health service implementations of omics and digital health technologies), and related health policy.
Professor Baynam also leads a 3D facial analysis research group with a resultant research, software tools and collaborative ecosystem deployed across four continents. He is a co-founder of the Undiagnosed Diseases Network International which globally integrates more than 140 leading clinical academic centres with programs supported by multiple national institutes of health, or their equivalents.
Professor Baynam has chaired multiple international multi-stakeholder taskforces (e.g. via International Rare Diseases Research Consortium) on rare diseases. The outputs have helped to coordinate and shape international research and clinical practice.
Professor Baynam’s projects include:
Lyfe Languages – Indigenous Youth driven Universal Indigenous Medical Translator
Cliniface – unlocking facial clues for diagnosis, care, treatment and clinical trial monitoring
INNOVaTR – INNOvative Therapies and trials for Rare diseases
CaRelink – linking rare diseases diagnosis through to treatment, care and support
Treatments for those that have none – delivering novel therapies for children with rare diseases
Research contributions
Professor Baynam has published > 150 peer reviewed publications, and 3 book chapters in genetic and rare diseases, clinical informatics, policy, multi-stakeholder consultation and implementation.
In the last five years, he has had first or senior authorship in Cell and Nature Genetics (x2) and an author in Nature, Nature Reviews Drug Discovery (x2), Nature Reviews Genetics (x2). H-index 39, citations >7000.
